Ubs Group Ag Retractable Technologies Inc Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVP
# of Institutions
33Shares Held
2.35MCall Options Held
2.7KPut Options Held
100-
Vanguard Group Inc Valley Forge, PA690KShares$441,2850.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny330KShares$211,2720.0% of portfolio
-
Black Rock Inc. New York, NY274KShares$175,3440.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX159KShares$101,7360.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$76,2660.0% of portfolio
About RETRACTABLE TECHNOLOGIES INC
- Ticker RVP
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 32,937,200
- Market Cap $21.1M
- Description
- Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...